Literature DB >> 8430355

Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin.

D G Addiss1, M L Vaughn, D Ludka, J Pfister, J P Davis.   

Abstract

The effectiveness of selective screening for control of Chlamydia trachomatis is unknown. In 1986, a statewide screening program began in family planning clinics in Wisconsin after the prevalence of infection among women was found to be 10.7% in four nonurban clinics and 13.7% in an urban Milwaukee clinic. In 1990, endocervical specimens were obtained from 1,757 women attending these same clinics; 5.2% of women in the non-urban clinics and 6.9% in the Milwaukee clinic tested positive for C. trachomatis. Prevalence of infection had decreased similarly (by 53% overall) in both high- and low-risk groups in all five clinics. Although reported condom use increased from 16% to 31%, most other demographic and behavioral risk factors for infection did not significantly change; in contrast, the prevalence of clinical signs of infection decreased. The percentage of infections identified by selective screening criteria decreased from 77% to 55%. Selective screening and attendant activities, as well as an increase in condom use, were associated with a decrease in prevalence of C. trachomatis infection in this population.

Entities:  

Keywords:  Americas; Biology; Chlamydia--women; Delivery Of Health Care; Demographic Factors; Developed Countries; Diseases; Examinations And Diagnoses; Family Planning Centers; Health; Health Facilities; Infections; Laboratory Examinations And Diagnoses; Measurement; North America; Northern America; Population; Population Characteristics; Prevalence--changes; Reproductive Tract Infections; Research Methodology; Risk Factors; Rural Population--women; Screening; Sexually Transmitted Diseases; United States; Urban Population--women; Wisconsin

Mesh:

Year:  1993        PMID: 8430355     DOI: 10.1097/00007435-199301000-00006

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  25 in total

1.  Prevalence of Chlamydia trachomatis infections in women attending six women's healthcare units in Kaunas, Lithuania.

Authors:  M Domeika; R Butylkina; A Hallén; T Spukaite; V Juceviciute; D Morkunaite; R Jakutiene; V Paliuniene; J Barakauskiene; M Goberis
Journal:  Sex Transm Infect       Date:  2001-12       Impact factor: 3.519

2.  Evidence based health policy report. Screening for genital chlamydial infection.

Authors:  J Pimenta; M Catchpole; M Gray; J Hopwood; S Randall
Journal:  BMJ       Date:  2000-09-09

3.  Modelling the healthcare costs of an opportunistic chlamydia screening programme.

Authors:  E J Adams; D S LaMontagne; A R Johnston; J M Pimenta; K A Fenton; W J Edmunds
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

4.  Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis.

Authors:  M Egger; N Low; G D Smith; B Lindblom; B Herrmann
Journal:  BMJ       Date:  1998-06-13

5.  Controlling genital chlamydial infection.

Authors:  A M Johnson; L Grun; A Haines
Journal:  BMJ       Date:  1996-11-09

6.  Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs.

Authors:  B Van Der Pol; D V Ferrero; L Buck-Barrington; E Hook; C Lenderman; T Quinn; C A Gaydos; J Lovchik; J Schachter; J Moncada; G Hall; M J Tuohy; R B Jones
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 7.  It takes 2: partner attributes associated with sexually transmitted infections among adolescents.

Authors:  Andrea Swartzendruber; Jonathan M Zenilman; Linda M Niccolai; Trace S Kershaw; Jennifer L Brown; Ralph J Diclemente; Jessica M Sales
Journal:  Sex Transm Dis       Date:  2013-05       Impact factor: 2.830

8.  Opportunistic screening for genital chlamydial infection. I: acceptability of urine testing in primary and secondary healthcare settings.

Authors:  J M Pimenta; M Catchpole; P A Rogers; E Perkins; N Jackson; C Carlisle; S Randall; J Hopwood; G Hewitt; G Underhill; H Mallinson; L McLean; T Gleave; J Tobin; V Harindra; A Ghosh
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

9.  Risk factors for genital chlamydial infection.

Authors:  Christine Navarro; Anne Jolly; Rama Nair; Yue Chen
Journal:  Can J Infect Dis       Date:  2002-05

10.  The chlamydia screening studies: rationale and design.

Authors:  N Low; A McCarthy; J Macleod; C Salisbury; P J Horner; T E Roberts; R Campbell; A Herring; S Skidmore; E Sanford; J A C Sterne; G Davey Smith; A Graham; M Huengsberg; J Ross; M Egger
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.